Factors associated with health-related quality of life (HRQoL) deterioration in glioma patients during the progression-free survival period.
Marijke B CoomansLinda DirvenNeil AaronsonBrigitta G BaumertMartin J Van Den BentAndrew BottomleyAlba A BrandesOlivier ChinotCorneel CoensThierry GorliaUlrich HerrlingerFlorence Keime-GuibertAnnika MalmströmFrancesca MartinelliRoger StuppAndrea TalacchiMichael WellerWolfgang WickJaap C ReijneveldMartin J B TaphoornPublished in: Neuro-oncology (2022)
HRQoL was maintained in only 53% of patients in their progression-free period, and treatment was not independently associated with this deterioration in HRQoL. Routine monitoring of the patients' functioning and well-being during the entire disease course is therefore important, so that interventions can be initiated when problems are signaled.